Total Payments
$3,716
2024 Payments
$329.31
Companies
18
Transactions
230
Medicare Patients
674
Medicare Billing
$77,530
Payment Breakdown by Category
Food & Beverage$3,716 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,716 | 230 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC | $1,165 | 63 | $0 (2024) |
| ABBVIE INC. | $960.66 | 60 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $656.84 | 51 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $159.85 | 15 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $148.62 | 10 | $0 (2022) |
| Echosens North America, Inc. | $138.67 | 1 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $98.15 | 6 | $0 (2017) |
| Nestle HealthCare Nutrition Inc. | $78.50 | 5 | $0 (2022) |
| Allergan Inc. | $70.40 | 5 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $65.35 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $329.31 | 18 | ABBVIE INC. ($144.77) |
| 2023 | $409.19 | 21 | Ironwood Pharmaceuticals, Inc ($244.99) |
| 2022 | $379.67 | 22 | ABBVIE INC. ($102.11) |
| 2021 | $488.38 | 29 | Ironwood Pharmaceuticals, Inc ($183.97) |
| 2020 | $343.69 | 22 | IRONWOOD PHARMACEUTICALS, INC ($203.85) |
| 2019 | $467.52 | 24 | AbbVie, Inc. ($180.62) |
| 2018 | $780.97 | 53 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($274.12) |
| 2017 | $517.24 | 41 | Valeant Pharmaceuticals North America LLC ($159.85) |
All Payment Transactions
230 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.33 | General |
| Category: GI | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.65 | General |
| Category: GI | ||||||
| 10/31/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.91 | General |
| Category: GI | ||||||
| 09/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: GI | ||||||
| 09/24/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/29/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.19 | General |
| Category: GI | ||||||
| 08/28/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/04/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| Category: GI | ||||||
| 02/10/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: GI | ||||||
| 12/05/2023 | AbbVie Inc. | VIBERZI (Drug), CREON, LINZESS | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2023 | AbbVie Inc. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: VIROLOGY | ||||||
| 10/31/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: GI | ||||||
| 10/25/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.62 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 147 | 153 | $160,873 | $18,399 |
| 2022 | 6 | 207 | 258 | $171,849 | $27,357 |
| 2021 | 7 | 176 | 201 | $117,492 | $20,124 |
| 2020 | 3 | 144 | 159 | $71,933 | $11,649 |
Total Patients
674
Total Services
771
Medicare Billing
$77,530
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 24 | $34,224 | $4,962 | 14.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $59,056 | $4,258 | 7.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 13 | 13 | $13,906 | $2,332 | 16.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $13,344 | $2,244 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 22 | $7,656 | $2,227 | 29.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $29,843 | $1,678 | 5.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,844 | $699.20 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 130 | $45,240 | $12,567 | 27.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 22 | 22 | $31,372 | $4,522 | 14.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $15,176 | $3,403 | 22.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 37 | $41,588 | $3,268 | 7.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 26 | 26 | $34,918 | $2,731 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 15 | $3,555 | $866.60 | 24.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 101 | $35,148 | $9,552 | 27.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 14 | 14 | $19,964 | $2,763 | 13.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 23 | 24 | $26,976 | $2,148 | 8.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $8,672 | $2,075 | 23.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 13 | 13 | $17,459 | $1,396 | 8.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 21 | $4,977 | $1,198 | 24.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $4,296 | $992.75 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 59 | $20,164 | $5,058 | 25.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 54 | 63 | $12,899 | $3,326 | 25.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 34 | 37 | $38,870 | $3,264 | 8.4% |
About Dr. Jaime Rivera, M.D
Dr. Jaime Rivera, M.D is a Gastroenterology healthcare provider based in Kissimmee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508894296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jaime Rivera, M.D has received a total of $3,716 in payments from pharmaceutical and medical device companies, with $329.31 received in 2024. These payments were reported across 230 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,716).
As a Medicare-enrolled provider, Rivera has provided services to 674 Medicare beneficiaries, totaling 771 services with total Medicare billing of $77,530. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Kissimmee, FL
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1508894296
Products in Payments
- Linzess (Drug) $948.42
- LINZESS (Drug) $342.79
- XIFAXAN (Drug) $314.11
- CREON (Drug) $154.08
- Dexilant (Drug) $142.20
- Fibroscan (Device) $138.67
- MAVYRET (Drug) $118.43
- MOVIPREP (Drug) $107.62
- Mavyret (Drug) $107.47
- RELISTOR (Drug) $106.43
- TRULANCE (Drug) $95.66
- Humira (Biological) $91.61
- HUMIRA (Biological) $91.41
- ZENPEP (Drug) $78.50
- OCALIVA (Drug) $65.35
- SKYRIZI (Biological) $61.08
- XIFAXANIBSD (Drug) $58.35
- VIBERZI (Drug) $48.86
- Creon (Drug) $48.15
- VOQUEZNA (Drug) $44.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Kissimmee
Muhammad Mohiuddin, M.d, M.D
Gastroenterology — Payments: $31,603
Gastroenterology $31,603
Basher Atiquzzaman, M.d, M.D
Gastroenterology — Payments: $12,502
Gastroenterology $12,502
Celia Quinnonez, Md, MD
Gastroenterology — Payments: $8,430
Gastroenterology $8,430
Abdul Bhutta, Md, MD
Gastroenterology — Payments: $2,840
Gastroenterology $2,840
Dr. Seela Ramesh, M.d, M.D
Gastroenterology — Payments: $2,414
Gastroenterology $2,414
Dr. Charles Bisogno, D.o, D.O
Gastroenterology — Payments: $1,505
Gastroenterology $1,505